Thu. 16 May 2024, 9:31am ET
Benzinga
Earnings, News
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.24) per share. This is a 14.29 percent increase over losses of $(0.28) per share from the same period last year. The company reported $56.00 thousand in sales this quarter. This is the same as the same period last year.